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Introduction: Takayasu arteritis is a relatively rare type of large-vessel arteritis that primarily affects the aorta and its
major branches, the coronary arteries, and the pulmonary arteries. Depending on the different groups of blood
vessels involved in the disease process, the clinical presentation of Takayasu arteritis varies. Here we report a case of
a woman presenting with a debilitating massive cerebral ischemic infarct that turned out to be a relatively rare first
presentation of Takayasu arteritis.
Case presentation: A 35-year-old Chinese woman presented to the Emergency Department with left hemiparesis,
pain and numbness of her arms and weak radial pulses. Her laboratory results showed an elevated C-reactive
protein and erythrocyte sedimentation rate, and subsequent digital subtraction angiography demonstrated
narrowing and occlusion of the major branches of her aortic arch. We report the case of a patient with Takayasu
arteritis presenting with a massive cerebral ischemic infarct and review the current literature on this topic.
Conclusion: Takayasu arteritis is a relatively rare disease with various and sometimes devastating clinical
manifestations, such as massive cerebral ischemic infarction as in our case. Currently, there are multiple diagnostic
tools and treatment options available, and more under investigation. Early, appropriate diagnosis and initiation of
proper therapy could avoid further progression and reduce complications of the disease.Introduction
Takayasu arteritis is a relatively rare type of large-vessel
arteritis that primarily affects the aorta and its major
branches, the coronary arteries, and the pulmonary ar-
teries. Here we report a case of a woman presenting with
debilitating massive cerebral ischemic infarction that
turned out to be Takayasu arteritis.Case presentation
A 35-year-old Chinese woman presented to the Emer-
gency Department (ED) after a fall 12 hours previously
and with an inability to move her left limbs since then.
She complained of feeling pain and numbness in her
arms for the past month, as well as progressive weak-
ness in her legs. She had never been pregnant, had no* Correspondence: wangyusun@hotmail.com
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reproduction in any medium, provided the orsignificant past medical or surgical history, nor was she
on any medications such as oral contraceptive pills.
There was no family history of early onset cerebral vascu-
lar accident. She denied the use of alcohol, tobacco prod-
ucts or recreational drugs. On physical examination, she
was conscious and irritable, her heart rate was 88 beats
per minute (bpm), blood pressure (BP) was recorded as
140/90mmHg upon ED presentation. She had no fever or
respiratory distress. She was unable to open her right eye
and had a right-sided preferred gaze with slight right-
sided facial droop. There was obvious left-sided hemipar-
esis with a positive Babinski sign, and the skin of her left
side felt cold. The radial pulse was weak on both sides.
The rest of her neurological, systemic, and general phys-
ical examinations was unremarkable.
Her laboratory test results showed white blood cells
(WBCs) of 13.9x109/L, hemoglobin (Hb) of 70.2g/L,
and platelets (PLTs) of 288x109/L. Her basic metabolic
panel was unremarkable. Her coagulation test was only
significant for elevated D-dimer of 1.08mg/L, whichral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Brain magnetic resonance imaging (MRI) scan showing massive acute ischemic infarct.
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her hospital stay, with partial thromboplastin time (PT)
and activated partial thromboplastin time (APTT) both
within normal limits. The lipid panel showed slightly
elevated cholesterol of 5.83mmol/L (2.85 to 5.2mmol/L),
triglyceride of 1.79mmol/l (0.5 to 1.7mmol/L) and lipo-
protein A of 373 (0 to 300). Her inflammatory biomarkers
such as C-reactive protein (CRP) and erythrocyte sedimen-
tation rate (ESR) were both elevated, with 26.0mg/L (0 to
8.0mmol/L) and 25mm/h (0 to 20mm/h) respectively.
Rapid plasma reagin (RPR)/treponema pallidum par-
ticle agglutination (TPPA) tests were negative. Auto-
antibody tests showed positive for antinuclear antibody
only, with a titer of 1:100, while the antiphosphlipid anti-
body test was negative. Her blood glucose, liver and renal
functions were all normal. Her electrocardiogram (EKG)
and transthoracic echocardiogram were both negative. A
cerebral magnetic resonance imaging (MRI) scan showed
acute ischemic infarction of the area supplied by the right
middle cerebral artery (Figure 1), which was proven
to be occluded by later cerebral computed tomographic
angiography (CTA) (Figure 2). Thoracic and abdominalFigure 2 Head computed tomographic angiography (CTA) showing a
(red circle).CTA was negative (Figure 3). A Doppler sonogram of the
vessels in the neck, upper and lower limbs was unable to
find both axillary arteries or the left subclavian artery. It
did show decreased blood flow in the arteries of her right
arm, with a narrowed right subclavian artery. The arter-
ies distal to the brachial artery were visible on both sides,
with a greater blood flow on the left. Subsequent digital
subtraction angiography (DSA) confirmed the incomplete
occlusion of her right subclavian artery and narrowing of
her right internal carotid artery (Figure 4).
The diagnosis of Takayasu arteritis type I was made
according to the revised Ishikawa diagnostic criteria [1]
and the angiographic classification of Takayasu arteritis
put forward at the Takayasu Conference 1994 [2]. Subse-
quently, the recommended treatment of methylpredniso-
lone was started with an initial dose of 40mg per day. As
the antinuclear antibody test was positive, autoimmune
diseases such as systemic lupus erythematosus (SLE) could
not be excluded, which in the light of the existing throm-
bosis, could be related to a hypercoagulation state. Thus a
small dose of low-molecular-weight heprin (LMWH) was
started along with the steroid.bsence of the middle cerebral artery (MCA) on the right side
Figure 3 Thoracic and abdominal computed tomographic angiography (CTA) was negative.
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patient was stable, and she was subsequently discharged.
Discussion
The most common types and clinical presentations of
Takayasu arteritis vary in different ethnic groups [3]. A
retrospective study of 125 patients with Takayasu arter-
itis conducted by Cong et al. suggested that the most
common type in the Chinese population is type I [4],
which our patient fell into. However, according to the
same study, the most common clinical manifestation
of Takayasu arteritis in China is pulse deficit (71.2%)
followed by hypertension (65.6%), and the common
neurological findings tend to be dizziness (50.4%) and
visual disturbance (33.6%) [5]. The presentation of our
patient is relatively rare and devastating, thus raising
the question of the etiology of her ischemic stroke.
Based on her clinical manifestation and MRI scan, this
cerebral vascular accident seemed to be embolic in na-
ture. There are several possible explanations of the
source of the embolus. A cardiac source was probablyFigure 4 Digital subtraction angiography (DSA) showing occlusion of
carotid artery.excluded by the negative transthoracic echocardiogram,
although a transesophageal echocardiogram with bubble
study was not done. There was a similar case reported
by Kato et al. who suggested a stump of the occluded
common carotid artery leading to turbulence of blood
flow as a possible source of embolization [6]. We also
suspected the coexistence of a hypercoagulation state
in our patient. In our review of the existing literature,
some studies suggested that Takayasu arteritis itself could
cause an overactivation of the coagulation system via
different pathways [5,7,8]. In the meanwhile, there are
reported cases of Takayasu arteritis where the anti-
bodies of antiphosphlipid syndrome were also positive
[9-12], which were related to more severe clinical courses.
In our case, the antiphosphlipid antibody itself was
negative, but there are other entities of antiphosphlipid
syndrome that we failed to test for due to an availability
issue [13]. The positive antinuclear antibody result also
raised suspicion of autoimmune disorders such as SLE,
which could cause hypercoagulation as well. Thus, the
empiric anticoagulation therapy was warranted.the right subclavian artery and narrowing of the right internal
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these technologies, CTA is considered to be more sensi-
tive to large-vessel lesions rather than relatively small
vessels such as the distal portions of aortic branches
[14,15] and has a lesser resolution compared to ultra-
sound [16]. But overall, CTA and Doppler both have
great sensitivity and specificity in terms of the diagnosis
of Takayasu arteritis, and they are able to show early
changes in the vessel wall that DSA fails to illustrate.
The method we did not use on this patient is positron
emission tomography/computed tomography (PET/CT)
due to issues of cost and radiation exposure. As a func-
tional imaging modality, PET/CT is able to pick up sites
of active inflammation, which makes it a useful tool in
detecting the early-stage vascular lesions and monitoring
the activity of the disease [17]. In regard to treatment
options of Takayasu arteritis, corticosteroid remains the
first-line medical therapy in the active disease process.
In our patient, since the clinical and laboratory manifes-
tations were both improving with steroid use only, other
immunosuppressants were not used. Surgical interven-
tions such as angioplasty and vascular reconstruction
are also recommended for severe stenosis or occlusion
of critical arteries, between which surgical bypass is con-
sidered to have superior potency but more serious early
postoperative complications as well [18]. While there is
no commonly accepted criteria for the indications of
surgical intervention in Takayasu arteritis, cerebro-
vascular ischemia, as presented in this case, is considered
a strong indication [19,20]. However, the nature of
Takayasu arteritis as an inflammatory disease raises the
failure and complication rate of surgical interventions
[21] and surgery is contraindicated in the acute phase of
the disease. So this treatment option will be discussed
during the subsequent follow-ups of our patient.
As seen in our patient, Takayasu arteritis can cause
devastating damage to the overall health condition and
quality of life, or even be life-threatening sometimes. So
it would be beneficial to diagnose the disease at an early
stage and monitor its activity and progression, which
remains a challenge that physicians and experts all over
the world have been working on, due to such a wide
range of clinical manifestations this disease can present
with. In our patient, initial physical examination demon-
strated reduced radial pulses on both sides, which raised
suspicion of Takayasu arteritis. According to a recent
study, individual physical examination findings had poor
sensitivity and good to excellent specificity [22]. While
various imaging techniques and blood levels of CRP and
ESR remain the most useful tools and the gold standard
in diagnosing and monitoring the progress of the disease,
several biomarkers have been suggested by recent studies
as well, which include IL-6 [23], matrix metalloproteinase
(MMP)-2, MMP-3, MMP-9 and pentraxin 3 (PTX3) [24].But all of these biomarkers are still under investigation
and none of them has showed a clear-cut correlation with
the disease activity. As a result, the historical Ishikawa
clinical classification of Takayasu arteritis [25] is still
widely used to determine prognosis and treatment plan.
If diagnosed at an early stage, the disease could be con-
trolled with the standard therapies discussed earlier, as
well as surgical intervention if critical vessels are in-
volved, so that debilitating and irreversible complica-
tions such as massive cerebral ischemic infarction may
not ensue.
Conclusion
Takayasu arteritis is a relatively rare disease with various
and sometimes devastating clinical manifestations, such
as the massive cerebral ischemic infarct in our case. Cur-
rently, there are multiple diagnostic tools and treatment
options available, and more under investigation. Early,
appropriate diagnosis and initiation of proper therapy
could avoid further progression and reduce complica-
tions of the disease.
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